ZBNA
CRNX icon

Zions Bancorporation, National Association’s Crinetics Pharmaceuticals CRNX Stock Holding History

Zions Bancorporation, National Association’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48K Sell
93
-104
-53% -$3.87K ﹤0.01% 1174
2026
Q1 		$7.16K Buy
197
+175
+795% +$7.82K ﹤0.01% 919
2025
Q4 		$1.02K Buy
+22
New +$979 ﹤0.01% 1110

Other funds holding CRNX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Zions Bancorporation, National Association's CRNX Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Crinetics Pharmaceuticals (CRNX) stake by 53% in Q2 2026, selling an estimated $3.87K and leaving 93 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Zions Bancorporation, National Association first reported a position in CRNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.16K in Q1 2026. 64 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Zions Bancorporation, National Association held 93 shares of Crinetics Pharmaceuticals worth $3.48K as of Q2 2026.
  • Zions Bancorporation, National Association sold 104 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $3.87K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1174 holding.
  • Zions Bancorporation, National Association first reported a position in Crinetics Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Zions Bancorporation, National Association's Crinetics Pharmaceuticals position peaked at $7.16K in Q1 2026.
  • 64 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.